Advertisement
| combination therapy for depression: Pharmacological Treatment of Mental Disorders in Primary Health Care World Health Organization, 2009 This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process. |
| combination therapy for depression: Fluoxetine Graziano Pinna, 2015-04-01 Fluoxetine, best known by the trade name Prozac®, unlike other psychotropic drugs whose effects were serendipitously stumbled upon, was the first developed for a precise mechanism of action, that is, the ability to selectively inhibit serotonin reuptake, based upon the theory that increasing the availability of serotonin would treat major depression. Once approved by the FDA in 1987, fluoxetine quickly became the most prescribed psychotropic drug worldwide and its success in improving mood disorders has triggered the development of a large number of congener molecules, commonly known as SSRIs after their purported mechanism of action. However, a quarter of a century after its development, the idea that fluoxetine asserts its positive behavioral effect through inhibition of serotonergic reuptake is not firmly established. This book reviews several preclinical and clinical reports suggesting that the pharmacological effects of fluoxetine may be mediated by means other than the regulation of serotonin, including the regulation of gene expression, modifying epigenetic mechanisms as well as modifying microRNAs. One of the most prominent mechanisms for the therapeutic relevance of fluoxetine relates to influencing neuroplasticity by enhancing neurotropic factors, including BDNF signaling and altering adult neurogenesis. The ability of fluoxetine to rapidly increase neurosteroid levels accounts for the fast anxiolytic effects of this drug. Fluoxetine action at sigma-1 receptor or modulating glutamatergic neurotransmission as well as the combination of fluoxetine with other psychotropic drugs is discussed in relation to its therapeutic effects. While fluoxetine was primarily prescribed as an antidepressant, this drug currently represents a treatment of choice for a broad spectrum of psychiatric disorders, including post-traumatic stress disorder and a range of anxiety disorders. This drug even possesses analgesic actions and is a valuable therapy for stroke. This book also highlights emerging evidence on the gender-specific effects of fluoxetine, its potential adverse features, including its addiction liability in combination with psychostimulants, and the impact of perinatal fluoxetine exposure. |
| combination therapy for depression: A Guide To Treatments that Work Peter Nathan, Jack M. Gorman, 2002-01-18 A fully revised and updated edition of this unique and authoritative reference The award-winning A Guide to Treatments that Work , published in 1998, was the first book to assemble the numerous advances in both clinical psychology and psychiatry into one accessible volume. It immediately established itself as an indispensable reference for all mental health practitioners. Now in a fully updated edition,A Guide to Treatments that Work, Second Edition brings together, once again, a distinguished group of psychiatrists and clinical psychologists to take stock of which treatments and interventions actually work, which don't, and what still remains beyond the scope of our current knowledge. The new edition has been extensively revised to take account of recent drug developments and advances in psychotherapeutic interventions. Incorporating a wealth of new information, these eminent researchers and clinicians thoroughly review all available outcome data and clinical trials and provide detailed specification of methods and procedures to ensure effective treatment for each major DSM-IV disorder. As an interdisciplinary work that integrates information from both clinical psychology and psychiatry, this new edition will continue to serve as an essential volume for practitioners of every kind: psychiatrists, psychologists, clinical social workers, counselors, and mental health consultants. |
| combination therapy for depression: Treating Resistant Depression Joseph Zohar, Robert H. Belmaker, 1987 |
| combination therapy for depression: Bergin and Garfield's Handbook of Psychotherapy and Behavior Change Michael J. Lambert, 2013-01-14 Praise for Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, Sixth Edition Not only is this a unique resource, it is the only book that all practitioners and researchers must read to ensure that they are in touch with the extraordinary advances that the field has made over the last years. Many of us have all five previous editions; the current volume is an essential addition to this growing, wonderful series. —Peter Fonagy, PhD, FBA, Freud Memorial Professor of Psychoanalysis and Head of the Research Department of Clinical, Educational and Health Psychology, University College London As either researcher or clinician living in the contemporary world of accountability, this invaluable edition of the Handbook is a must for one's professional library. —Marvin R. Goldfried, PhD, Distinguished Professor of Psychology, Stony Brook University The classic reference on psychotherapy—revised for the twenty-first century Keeping pace with the rapid changes that are taking place in the field, Bergin and Garfield's Handbook of Psychotherapy and Behavior Change, Sixth Edition endures as the most important overview of research findings in psychotherapy for professionals, academics, researchers, and students. This bestselling resource presents authoritative thinking on the pressing questions, issues, and controversies in psychotherapy research and practice today. Thorough and comprehensive, the new edition examines: New findings made possible by neuro-imaging and gene research Qualitative research designs and methods for understanding emotional problems Research in naturalistic settings that capitalizes on the curiosity of providers of services Practice-relevant findings, as well as methodological issues that will help direct future research |
| combination therapy for depression: Diagnostic and Statistical Manual of Mental Disorders (DSM-5) American Psychiatric Association, 2021-09-24 |
| combination therapy for depression: Psychiatry Essentials for Primary Care Robert Kirwin Schneider, James L. Levenson, 2008 Psychiatry Essentials for Primary Care is an easy-to-use comprehensive source for physicians to help them recognize, screen, manage and refer various psychiatric disorders. Written specifically for the non-specialist, the book focuses on MAPSO (mood disorders, anxiety, psychosis, substance-induced and organic/other issues the most common disorders primary-care physicians encounter). Key concepts, in-depth tables, boxes, figures, and mnemonic devices help to present a thorough overview of these disorders and findings in a concise and practical manner. Psychiatry Essentials for Primary Care also features the current standards of care. |
| combination therapy for depression: The Practice of Electroconvulsive Therapy American Psychiatric Association, 2008-08-13 Since the development of pharmacoconvulsive therapy in 1934 and of electroconvulsive therapy (ECT) in 1938, ECT has proven far more valuable than just the intervention of last resort. In comparison with psychotropic medications, we now know that ECT can act more effectively and more rapidly, with substantial clinical improvement that is often seen after only a few treatments. This is especially true for severely ill patients -- those with severe major depression with psychotic features, acute mania with psychotic features, or catatonia. For patients who are physically debilitated, elderly, or pregnant, ECT is also safer than psychotropic medications. The findings of the American Psychiatric Association (APA) Task Force on ECT were published by the APA in 1990 as the first edition of The Practice of Electroconvulsive Therapy, inaugurating the development of ECT guidelines by groups both within the United States and internationally. Since then, advances in the use of this technically demanding treatment prompted the APA to mandate a second edition. The updated format of this second edition presents background information followed by a summary of applicable recommendations for each chapter. This close integration of the recommendations with their justifications makes the material easy to read, understand, and use. To further enhance usability, recommendations critical to the safe, effective delivery of treatment are marked with the designation should to distinguish them from recommendations that are advisable but nonessential (with the designations encouraged, suggested, considered). The updated content of this second edition, which spans indication for use of ECT, patient evaluation, side effects, concurrent medications, consent procedures (with sample consent forms and patient information booklet), staffing, treatment administration, monitoring of outcome, management of patients following ECT, and documentation, as well as education, and clinical privileging. This volume reflects not only the wide expertise of its contributors, but also involved solicitation of input from a variety of other sources, including applicable medical professional organizations, individual experts in relevant fields, regulatory bodies, and major lay mental health organizations. In addition, the bibliography of this second edition is based upon an exhaustive search of the clinical ECT literature over the past decade and contains more than four times the original number of citations. Complemented by extensive annotations and useful appendixes, this remarkably comprehensive yet practical overview will prove an invaluable resource for practitioners and trainees in psychiatry and related disciplines. |
| combination therapy for depression: ACT for Depression Robert D. Zettle, 2007 ACT for Depression adapts the research-proven techniques of acceptance and commitment therapy (ACT) into a powerful set of conceptualization, assessment, and treatment techniques clinicians can use to help clients with depression, the second-most common mental health condition. |
| combination therapy for depression: Treatment for Chronic Depression James P. McCullough, Jr., 2003-08-27 This volume describes the Cognitive Behavioral Analysis System of Psychotherapy (CBASP), a research-based approach designed to motivate chronically depressed patients to change and to help them develop needed problem-solving and relationship skills. Presenting clear, step-by-step guidelines for implementing CBASP--along with compelling empirical evidence that supports its efficacy--the book is filled with illustrative case material that brings challenging clinical situations to life. Also covered are ways to measure treatment outcomes and recommended procedures for training and supervision. |
| combination therapy for depression: Electroconvulsive Therapy in Children and Adolescents Neera Ghaziuddin, Garry Walter, 2013-12 This is a pioneering book about the use of ECT in adolescents who are diagnosed with severe, disabling psychiatric disorders or fail conventional treatment. Included are a review of the literature, firsthand experience of the authors and case descriptions making it an invaluable guide to treatment. |
| combination therapy for depression: Depression and Heart Disease Alexander Glassman, Mario M. Maj, Norman Sartorius, 2011-06-20 Recently, there has been a growing awareness of the multiple interrelationships between depression and various physical diseases. Patients with psychiatric problems, particularly depression, may be more susceptible to cardiovascular disorders. Depression and Heart Disease synthesizes current evidence, including some previously unpublished data, in a concise, easy-to-read format. The authors succinctly describe the epidemiology, pathogenesis (including cytokines and genetics), and risk factors of the comorbidity between depression and heart disease. The book also reviews the best pharmacological and psychotherapeutic approaches for people with this comorbidity. |
| combination therapy for depression: Versed Rae Armantrout, 2010-08 A collection of poetry organized in two sections. The first section, Versed, play with vice and versa, the perversity of human consciousness. They flirt with error and delusion, skating on a thin ice that inevitably cracks. The second section, Dark Matter, alludes to more than the unseen substance thought to make up the majority of mass in the universe. The invisible and unknowable are confronted directly as the author's experience with cancer marks these poems with a new austerity, shot through with her signature wit and stark unsentimental thinking.--Résumé de l'éditeur. |
| combination therapy for depression: Integrating Psychotherapy and Psychopharmacology Irismar Reis de Oliveira, Thomas Schwartz, Stephen M. Stahl, 2013-12-04 Integrating Psychotherapy and Psychopharmacology: A Handbook for Clinicians is a practical guide for the growing number of mental-health practitioners searching for information on treatments that combine psychopharmacology, psychotherapy, and psychosocial rehabilitation. Research shows that combined approaches are among the most effective ways to treat an increasing number of psychiatric disorders. However, though these combined treatments are becoming the everyday practice of psychiatrists, psychologists, and other mental-health professionals, identifying the right treatment plan can be notoriously difficult, and clinicians are often left scrambling to answer questions about how to design and customize their treatment strategies. In Integrating Psychotherapy and Psychopharmacology, readers will find these questions fully addressed and the answers explained, and they’ll come away from the book with a toolbox full of strategies for helping their patients improve symptoms, achieve remission, and stay well using a combination of drug and psychological treatments. |
| combination therapy for depression: Interpersonal Psychotherapy John C. Markowitz, 1998 The book compiles the results of several research studies on this subject. It discusses important developments in interpersonal psychotherapy research and its translation into clinical practice. It describes typical phases of treatments and highlights applications for patient populations, which have seen results from interpersonal psychotherapy. |
| combination therapy for depression: First Episode Psychosis Katherine J. Aitchison, Robin M. Murray, Patrick J. R. Power, Eva M. Tsapakis, 1999-02-17 The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. |
| combination therapy for depression: Mental Illness in General Health Care T. Bedirhan Üstün, Norman Sartorius, 1995-06-15 This book presents the largest international study of psychological disorders seen in primary health care. Centres in fourteen countries participated in this investigation, including Brazil, Chile, China, India, Nigeria and the USA as well as several European countries. The study has shown how people with mental disorders present their problems to doctors and how likely their disorders are to be detected and treated. |
| combination therapy for depression: DSM-5 Classification American Psychiatric Association, 2015-08-25 This handy DSM-5(R) Classification provides a ready reference to the DSM-5 classification of disorders, as well as the DSM-5 listings of ICD-9-CM and ICD-10-CM codes for all DSM-5 diagnoses. To be used in tandem with DSM-5(R) or the Desk Reference to the Diagnostic Criteria From DSM-5(R), the DSM-5(R) Classification makes accessing the proper diagnostic codes quick and convenient. With the advent of ICD-10-CM implementation in the United States on October 1, 2015, this resource provides quick access to the following: - The DSM-5(R) classification of disorders, presented in the same sequence as in DSM-5(R), with both ICD-9-CM and ICD-10-CM codes. All subtypes and specifiers for each DSM-5(R) disorder are included.- An alphabetical listing of all DSM-5 diagnoses with their associated ICD-9-CM and ICD-10-CM codes.- Separate numerical listings according to the ICD-9-CM codes and the ICD-10-CM codes for each DSM-5(R) diagnosis.- For all listings, any codable subtypes and specifiers are included with their corresponding ICD-9-CM or ICD-10-CM codes, if applicable. The easy-to-use format will prove indispensable to a diverse audience--for example, clinicians in a variety of fields, including psychiatry, primary care medicine, and psychology; coders working in medical centers and clinics; insurance companies processing benefit claims; individuals conducting utilization or quality assurance reviews of specific cases; and community mental health organizations at the state or county level. |
| combination therapy for depression: What Is Psychotherapy? The School of Life, 2018 An in-depth look at a much misunderstood practice, offering a fresh viewpoint on how this science can be a universally effective route to our better selves. |
| combination therapy for depression: The Psychological Treatment of Depression J. Mark G. Williams, 2013-01-11 'A clear, rigorous account of cognitive behavioural methods for treating depression.' - British Journal of Psychiatry The use of behavioural and cognitive techniques for treating depression has yielded exciting results. Cognitive Behaviour Therapy (CBT) is as effective in the short term as anti-depressant drugs and has longer-lasting effects than medication. This book brings together assessment and treatment techniques of proven efficacy, describing them in usable detail and setting them in the context of current psychological theories of depression. It is an invaluable guide to practitioners wishing to make use of CBT. |
| combination therapy for depression: Treatment of Depression , 1999 |
| combination therapy for depression: I Had a Black Dog Matthew Johnstone, 2012-03-01 'I Had a Black Dog says with wit, insight, economy and complete understanding what other books take 300 pages to say. Brilliant and indispensable.' - Stephen Fry 'Finally, a book about depression that isn't a prescriptive self-help manual. Johnston's deftly expresses how lonely and isolating depression can be for sufferers. Poignant and humorous in equal measure.' Sunday Times There are many different breeds of Black Dog affecting millions of people from all walks of life. The Black Dog is an equal opportunity mongrel. It was Winston Churchill who popularized the phrase Black Dog to describe the bouts of depression he experienced for much of his life. Matthew Johnstone, a sufferer himself, has written and illustrated this moving and uplifting insight into what it is like to have a Black Dog as a companion and how he learned to tame it and bring it to heel. |
| combination therapy for depression: Interpersonal Psychotherapy of Depression Gerald L. Klerman, Myrna M. Weissman, 1994-10-01 Reflecting the new and exciting trends in psychotherapy as well as responsive to the current emphasis on efficient, substantial therapeutic results, this book presents a model of interpersonal, short_term psychotherapy for clinically depressed patients. Gerald L. Klerman, whose research on depression has made him world renowned, and Myrna M. Weissman, who has written, with Eugene Paykel, an important book on women and depression, have worked with their colleagues to present the empirical basis for their new treatment method. This theory builds on the heritage of Harry Stack Sullivan and John Bowlby and their focus on interpersonal issues and attachment on depression. Research shows that four categories of interpersonal difficulties predominate: grief, interpersonal disputes, role transitions. and interpersonal deficits. In this approach, the therapist focuses on the patient's primary problems and evaluates the need for medication in addition to interpersonal therapy. Acknowledging that these four areas are never mutually exclusive, the authors present a clear treatment strategy for each, augmenting their presentation with a discussion of common obstacles that arise during treatment. As an overview, the book compares interpersonal psychotherapy with other psychotherapies for depression. Summaries of research documenting the efficacy of interpersonal psychotherapy are given.The authors outline the theoretical basis for an interpersonal approach, and apply it to depression. The following sections detail how to conduct interpersonal psychotherapy, supplying case vignettes to illustrate particular problems. Finally, the authors explore combining interpersonal psychotherapy with pharmacotherapy. |
| combination therapy for depression: Ketamine for Treatment-Resistant Depression Sanjay J. Mathew, Carlos A. Zarate, Jr., 2016-11-25 This book brings together an international group of clinicians and researchers from a broad swath of inter-related disciplines to offer the most up-to-date information about clinical and preclinical research into ketamine and second-generation “ketamine-like” fast-acting antidepressants. Currently available antidepressant medications act through monoaminergic systems, are ineffective for many individuals suffering from depression, and are associated with a delayed onset of peak efficacy of several months. The unexpected emergence of ketamine, an anesthetic N-methyl-D-aspartate (NMDA) receptor antagonist, as a rapid-acting antidepressant has reinvigorated CNS drug discovery research and catalyzed investigation in patient populations historically ignored in antidepressant drug development programs, particularly treatment-resistant patients and those with suicidality. Recent industry and academic research efforts have coalesced to explore NMDA receptor and glutamatergic molecular targets that lack ketamine’s psychotomimetic side effects and abuse liability but retain its rapid onset of efficacy. However, many fundamental questions remain regarding the neurobiological mechanisms underlying ketamine’s rapid antidepressant effects and the puzzling persistence of benefits observed in some patients following a single dose. This book examines how insights from these studies are forging new conceptual models of the neurobiology of stress-related affective, anxiety, and addictive disorders and the nature of treatment resistance. It also discusses how ketamine’s rapid antidepressant effects provide a scientific platform to facilitate innovation in clinical trial designs pertaining to patient selection, choice of control group, outcome measures, and dose-optimization. This book brings together data and insights from this rapidly expanding and extraordinarily promising field of study. Readers will be able to extract integrated themes and useful insights from the material contained in these diverse chapters and appreciate the paradigm-shifting contributions of ketamine to modern psychiatry and clinical neuroscience research. |
| combination therapy for depression: Depression in Parents, Parenting, and Children Institute of Medicine, National Research Council, Division of Behavioral and Social Sciences and Education, Board on Children, Youth, and Families, Committee on Depression, Parenting Practices, and the Healthy Development of Children, 2009-10-28 Depression is a widespread condition affecting approximately 7.5 million parents in the U.S. each year and may be putting at least 15 million children at risk for adverse health outcomes. Based on evidentiary studies, major depression in either parent can interfere with parenting quality and increase the risk of children developing mental, behavioral and social problems. Depression in Parents, Parenting, and Children highlights disparities in the prevalence, identification, treatment, and prevention of parental depression among different sociodemographic populations. It also outlines strategies for effective intervention and identifies the need for a more interdisciplinary approach that takes biological, psychological, behavioral, interpersonal, and social contexts into consideration. A major challenge to the effective management of parental depression is developing a treatment and prevention strategy that can be introduced within a two-generation framework, conducive for parents and their children. Thus far, both the federal and state response to the problem has been fragmented, poorly funded, and lacking proper oversight. This study examines options for widespread implementation of best practices as well as strategies that can be effective in diverse service settings for diverse populations of children and their families. The delivery of adequate screening and successful detection and treatment of a depressive illness and prevention of its effects on parenting and the health of children is a formidable challenge to modern health care systems. This study offers seven solid recommendations designed to increase awareness about and remove barriers to care for both the depressed adult and prevention of effects in the child. The report will be of particular interest to federal health officers, mental and behavioral health providers in diverse parts of health care delivery systems, health policy staff, state legislators, and the general public. |
| combination therapy for depression: Personalized Psychiatry Bernhard Baune, 2019-10-16 Personalized Psychiatry presents the first book to explore this novel field of biological psychiatry that covers both basic science research and its translational applications. The book conceptualizes personalized psychiatry and provides state-of-the-art knowledge on biological and neuroscience methodologies, all while integrating clinical phenomenology relevant to personalized psychiatry and discussing important principles and potential models. It is essential reading for advanced students and neuroscience and psychiatry researchers who are investigating the prevention and treatment of mental disorders. - Combines neurobiology with basic science methodologies in genomics, epigenomics and transcriptomics - Demonstrates how the statistical modeling of interacting biological and clinical information could transform the future of psychiatry - Addresses fundamental questions and requirements for personalized psychiatry from a basic research and translational perspective |
| combination therapy for depression: Managing Treatment-Resistant Depression Joao Luciano de Quevedo, Patricio Riva-Posse, William V. Bobo, 2022-04-04 Managing Treatment-Resistant Depression: Road to Novel Therapeutics defines TRD for readers, discussing the clinical and epidemiological predictors, economic burden and neurobiological factors. In addition, staging methods for treatment resistance are fully covered in this book, including serotonin specific reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, other classes of antidepressants, including tricyclic antidepressants and monoamine oxidase inhibitors, augmentation strategies, and newer antidepressant treatments like ketamine and esketamine. In addition, evidence supporting the use of psychotherapies and neuromodulation strategies are also reviewed. Written by top experts in the field, this book is the first of its kind to review all methods of treatment for TRD. Defines Treatment-Resistant Depression and Staging Treatment Intensity Includes Treatment-Resistant Depression options for children, adolescents, geriatrics, during pregnancy, and during post-partum and menopause transitions Discusses the use of Ketamine and Esketamine for treatment-resistant depression |
| combination therapy for depression: The Promise of Adolescence National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Division of Behavioral and Social Sciences and Education, Board on Children, Youth, and Families, Committee on the Neurobiological and Socio-behavioral Science of Adolescent Development and Its Applications, 2019-08-26 Adolescenceâ€beginning with the onset of puberty and ending in the mid-20sâ€is a critical period of development during which key areas of the brain mature and develop. These changes in brain structure, function, and connectivity mark adolescence as a period of opportunity to discover new vistas, to form relationships with peers and adults, and to explore one's developing identity. It is also a period of resilience that can ameliorate childhood setbacks and set the stage for a thriving trajectory over the life course. Because adolescents comprise nearly one-fourth of the entire U.S. population, the nation needs policies and practices that will better leverage these developmental opportunities to harness the promise of adolescenceâ€rather than focusing myopically on containing its risks. This report examines the neurobiological and socio-behavioral science of adolescent development and outlines how this knowledge can be applied, both to promote adolescent well-being, resilience, and development, and to rectify structural barriers and inequalities in opportunity, enabling all adolescents to flourish. |
| combination therapy for depression: Mindfulness-Based Cognitive Therapy for Depression, First Edition Zindel V. Segal, J. Mark G. Williams, John D. Teasdale, 2001-11-14 This book presents an innovative eight-session program that has been clinically proven to bolster recovery from depression and prevent relapse. Developed by leading scientist-practitioners, and solidly grounded in current psychological research, the approach integrates cognitive therapy principles and practice into a mindfulness framework. Clinicians from any background will find vital tools to help clients maintain gains made by prior treatment and to expand the envelope of care to remission and beyond. Illustrative transcripts and a wealth of reproducible materials, including session summaries and participant forms, enhance the clinical utility of the volume. More than 35 reproducibles are also provided in a large-size format on Guilford's website for bookbuyers to download. |
| combination therapy for depression: Scientific Standards of Psychological Practice Steven C. Hayes, 2007 A collection of essay in support of wider and more streamlined use of research results and higher levels of scientific practice standards in clinical psychology. |
| combination therapy for depression: Animal and Translational Models for CNS Drug Discovery Robert A. McArthur, Franco Borsini, 2008-11-27 Animal and Translational Models for CNS Drug Discovery combines the experience of academic, clinical and pharmaceutical neuroscientists in a unique collaborative approach to provide a greater understanding of the relevance of animal models of neuropsychiatric disorders and their role as translational tools for the discovery of CNS drugs being developed for the treatment of these disorders. The focus of this three-volume series of essays is to present a consensual picture of the translational value of animal models from leading experts actively involved in the use of animal models for understanding fundamental neurobiology of CNS disorders and the application of this knowledge to CNS drug discovery, and clinical investigators involved in clinical trials, drug development and eventual registration of novel pharmaceuticals. Each volume of the Animal and Translational Models for CNS Drug Discovery series is dedicated to the development and use of animal models in key therapeutic areas in psychiatric, neurologic and reward deficit disorders. Each volume has introductory chapters expressing the view of the role and relevance of animal models for CNS drug discovery and development from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in relevant therapeutic areas and discusses the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on Animal and Translational Models for CNS Drug Discovery is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. - Provides clinical, academic, government and industry perspectives fostering integrated communication between principle participants at all stages of the drug discovery process - Critical evaluation of animal and translational models improving transition from drug discovery and clinical development - Emphasizes what results mean to the overall drug discovery process - Explores issues in clinical trial design and conductance in each therapeutic area - Each volume is available for purchase individually. |
| combination therapy for depression: Psychiatric Pharmacogenomics David Mrazek, 2010-06-10 Psychiatric Pharmacogenomics is a book written to help clinicians to use pharmacogenomic testing to improve the pharmacotherapy that they provide for their patients. It is designed to teach clinicians how to order pharmacogenomic tests and interpret the results. Clinical examples are used to underscore the specific indications for pharmacogenomic testing and to clarify the clinical usefulness of identifying atypical genotypes that result in problematic responses to medication. The first section of the book begins with a basic review of molecular genetics. Additionally, the book also includes an extensive glossary of technical terms associated with molecular genetics and pharmacogenomics. The clinical utility of pharmacogenomic testing is demonstrated throughout the book by describing the implications of genetic variations for the care of individual patients. The second section of the book is organized into fourteen chapters that each focus on the clinical implications of testing for specific genes for which variants have been associated with either therapeutic response or side effects of psychotropic medications. Each of these chapters is structured in the same manner and involves a description of the gene and its significant variants. Each chapter also includes one or more clinical vignettes. The third section of the book discusses the clinical usefulness of pharmacogenomic testing, ethical issues associated with pharmacogenomic testing, and provides predictions for the future development of more sophisticated pharmacogenomic testing. |
| combination therapy for depression: Stress Echocardiography Eugenio Picano, 2015-10-06 This sixth edition is enriched by over 300 figures, 150 tables and a video-companion collecting more than 100 cases also presented in the format of short movies and teaching cartoons. This extensively revised and enlarged edition of this long-seller documents the very significant advances made since the fifth (2009) edition and is entirely written by Eugenio Picano, a pioneer in the field sharing his lifetime experience with the help of an international panel of 50 contributors from 22 countries representing some of the best available knowledge and expertise in their respective field. In a societal and economic climate of increasing pressure for appropriate, justified and optimized imaging, stress echocardiography offers the great advantages of being radiation-free, relatively low cost, and with a staggering versatility: we can get more (information) with less (cost and risk). For a long time, the scope and application of stress echo remained focused on coronary artery disease. In the last ten years, it has exploded in its breadth and variety of applications. From a black-and-white, one-fits-all approach (wall motion by 2D-echo in the patient with known or suspected coronary artery disease) now we have moved on to a omnivorous, next-generation laboratory employing a variety of technologies (from M-Mode to 2D and pulsed, continuous, color and tissue Doppler, to lung ultrasound and real time 3D echo, 2D speckle tracking and myocardial contrast echo) on patients covering the entire spectrum of severity (from elite athletes to patients with end-stage heart failure) and ages (from children with congenital heart disease to the elderly with low-flow, low-gradient aortic stenosis). |
| combination therapy for depression: Drug-Induced Liver Injury , 2019-07-13 Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series |
| combination therapy for depression: APA Handbook of Psychopharmacology Suzette M. Evans, Kenneth M. Carpenter, 2019 The APA Handbook of Psychopharmacology provides working knowledge of basic pharmacology and psychopharmacology, examines psychopharmacology for treatment of various emotional and behavioral conditions, and discusses related professional and social issues. |
| combination therapy for depression: Rang & Dale's Pharmacology James M. Ritter, Rod J. Flower, Graeme Henderson, Yoon Kong Loke, David MacEwan, Humphrey P. Rang, 2018-11-04 World-renowned coverage of today's pharmacology at your fingertips - Keeps you up-to-date with new information in this fast-changing field, including significantly revised coverage of CNS drugs, cognitive enhancers, anti-infectives, biologicals/biopharmaceuticals, lifestyle drugs, and more. - Includes access to unique features, including more than 100 brand new chapter-specific multiple-choice questions and 6 new cases for immediate self-assessment. - Features a color-coded layout for faster navigation and cross-referencing. - Clarifies complex concepts with Key Points boxes, Clinical Uses boxes and full-color illustrations throughout. |
| combination therapy for depression: The Management of Depression Stuart Checkley, 1998-04-15 With a prevalence of 3% to 5% in the general population, depression is the most common mental disorder. Ranging from the almost universal 'blues' to very severe psychotic states in which a patient suffers delusions, hallucinations and paranoia, depression is consequently managed by a wide variety of health-care groups, including GPs, social workers, psychologists, psychiatrists, nurses and counsellors. This book attempts to produce a synthesis of all relevant facts about this range of affective disorders and to make sense of the many different ways they present and are treated by health-care workers. The aims of this book are to describe the social, psychological and physical treatments of depression; to indicate the strengths, weaknesses and indications for each; and to show how they may be used together in the management of depression as it presents from primary to tertiary care and at different stages. |
| combination therapy for depression: Talking Back to Prozac Peter R. Breggin, Ginger Ross Breggin, 2014-04-01 A psychiatrist takes a critical look at this SSRI and newer medications that are among the most frequently prescribed drugs in America. Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro‐Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain—with few or no side effects. But is the reality quite different? At what price do we buy Prozac‐induced euphoria and a shiny new personality? Psychiatrist Peter Breggin, MD, and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works, and they take a hard look at the real story behind today’s most controversial drug: The fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval The difficulty Prozac’s manufacturer had in proving its effectiveness during these tests The information on side effects that the FDA failed to include in its final labeling requirements How Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine The dangers of possible Prozac addiction and abuse The seriousness and frequency of Prozac’s side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm The growing evidence that Prozac can cause violence and suicide The social and workplace implications of using the drug not to cure depression but to change personality and enhance performance Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it. |
| combination therapy for depression: The Midnight Library Matt Haig, 2021-01-27 Good morning America book club--Jacket. |
| combination therapy for depression: New Antiepileptic Drugs Francesco Pisani, 1991 The pharmacological fight against epilepsy began many centuries ago when Hippocrates discovered that the cause of epilepsy is natural, as opposed to supernatural and, as a consequence, must be treated with a natural remedy. Even though science has significantly progressed since that era, the challenge to find remedies for epilepsy is ever present. The aim of this particular volume is to offer an up-to-date review of the most recent advances in antiepileptic drug development, considered from various viewpoints: (i) general, by taking into account the size of refractory epilepsy and its related problems; (ii) experimental, by exploring the mechanisms of epileptogenesis and the possiblility of influencing it through drugs, and (iii) clinical, by describing the results obtained with compounds currently at an advanced stage of testing. |
Combination - Wikipedia
In mathematics, a combination is a selection of items from a set that has distinct members, such that the order of selection does not matter (unlike permutations). For example, given three …
Combinations and Permutations - Math is Fun
When the order doesn't matter, it is a Combination. When the order does matter it is a Permutation.
Combinations Calculator (nCr)
Sep 17, 2023 · The Combinations Calculator will find the number of possible combinations that can be obtained by taking a sample of items from a larger set. Basically, it shows how many …
Combinations - Definition, Formula, Examples, FAQs - Cuemath
Combinations are selections made by taking some or all of a number of objects, irrespective of their arrangements. The number of combinations of n different things taken r at a time, …
Permutations and Combinations - GeeksforGeeks
Apr 29, 2025 · Combination Formula. Combination Formula is used to choose ‘r’ components out of a total number of ‘n’ components, and is given by: Combination Formula. Using the above …
COMBINATION Definition & Meaning - Merriam-Webster
The meaning of COMBINATION is a result or product of combining; especially : an alliance of individuals, corporations, or states united to achieve a social, political, or economic end. How …
Definition of Combination in Math - BYJU'S
In mathematics, a combination is a way of selecting items from a collection where the order of selection does not matter. Suppose we have a set of three numbers P, Q and R. Then in how …
COMBINATION | English meaning - Cambridge Dictionary
COMBINATION definition: 1. the mixture you get when two or more things are combined: 2. an arrangement in a particular…. Learn more.
Combination - Math.net
In mathematics, a combination refers to a selection of objects from a collection in which the order of selection doesn't matter. Think of ordering a pizza.
Combinations | Brilliant Math & Science Wiki
A combination is a way of choosing elements from a set in which order does not matter. In general, the number of ways to pick \( k \) unordered elements from an \( n \) element set is \( …
Combination - Wikipedia
In mathematics, a combination is a selection of items from a set that has distinct members, such that the order of selection does not matter (unlike permutations). For example, given …
Combinations and Permutations - Math is Fun
When the order doesn't matter, it is a Combination. When the order does matter it is a Permutation.
Combinations Calculator (nCr)
Sep 17, 2023 · The Combinations Calculator will find the number of possible combinations that can be obtained by taking a sample of items from a larger set. Basically, it shows …
Combinations - Definition, Formula, Examples, FAQs - Cu…
Combinations are selections made by taking some or all of a number of objects, irrespective of their arrangements. The number of combinations of n different things …
Permutations and Combinations - GeeksforGeeks
Apr 29, 2025 · Combination Formula. Combination Formula is used to choose ‘r’ components out of a total number of ‘n’ components, and is given by: Combination Formula. Using the …
